Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Electronic applications for the CFQ-R scoring

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Validated and longitudinally stable asthma phenotypes based on cluster analysis of the ADEPT study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. High levels of biomarkers of collagen remodeling are associated with increased mortality in COPD - results from the ECLIPSE study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Plasma Cotinine Cutoff for Distinguishing Smokers From Nonsmokers Among Persons Living With HIV

    Research output: Contribution to journalJournal articleResearch

  2. Torque-Teno virus viral load as a potential endogenous marker of immune function in solid organ transplantation

    Research output: Contribution to journalReviewResearchpeer-review

  3. Markers of bone turnover are reduced in patients with CF related diabetes; the role of glucose

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Patient reported outcomes (PROs) have become widely accepted outcome measures in cystic fibrosis (CF) and other respiratory diseases. The Cystic Fibrosis-Questionnaire-Revised (CFQ-R) is the best validated and most widely used PRO for CF. Data collection can be time-intensive, and electronic platforms would greatly facilitate the feasibility, utility and accuracy of administration of the CFQ-R. Given that the CFQ-R is utilized in virtually all clinical trials worldwide and is increasingly integrated into clinical practice, we developed a software application that will help users to administer, score and save CFQ-R data for all versions. All codes are open access, which will enable other PRO users to design similar applications for other respiratory diseases, such as primary ciliary dyskinesia and non-CF bronchiectasis.

Original languageEnglish
JournalRespiratory Research
Volume18
Issue number1
Pages (from-to)e108
ISSN1465-9921
DOIs
Publication statusPublished - 30 May 2017

    Research areas

  • Letter

ID: 52170080